Furthermore, patients carrying an LRP6 mutation exhibit elevated levels of LDL-c, TC, and fasting glucose, which constitute the risk factors of the diseases including hypertriglyceridemia [30], hypercholesterolemia [31], atherosclerosis [32] and NAFLD [28]. Here, LRP6 is linked to metabolic dysfunction-associated steatotic liver disease.